ACURX PHARMACEUTICALS LLC (NASDAQ: ACXP)

NASDAQ: ACXP (Acurx Pharmaceuticals, Inc.)

最近更新时间: 3天之前, 10:13AM

-0.15 (-3.14%)

加入群组

股市价格/股市净资产 (P/B)

2.05

52周波幅	3.80 (-17%) — 44.90 (871%)
利润日期	13 Nov 2025

市场趋势

AIStockmoo 评分

1.6

相关股票

股票	市值	DY	P/E（TTM）	P/B
ACXP	7 M	-	-	2.05
MRNA	9 B	-	-	1.05
HRMY	2 B	-	11.90	2.83
MESO	2 B	-	-	2.97
ABCL	1 B	-	-	1.24
CVAC	1 B	-	5.37	1.78

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
部门	Healthcare
行业	Biotechnology
投资方式	Small Value
内部持股比例	10.95%
机构持股比例	18.21%

所有权

姓名	日期	持有股份
Prospect Financial Services Llc	30 Jun 2025	14,839
Sabby Management, Llc	30 Jun 2025	4,095
O'brien Greene & Co. Inc	30 Jun 2025	3,000
Vanguard Capital Wealth Advisors	30 Jun 2025	2,300
Act Advisors, Llc.	30 Jun 2025	2,298

公司	日期	目标价格	调整类型	价格@调整类型
HC Wainwright & Co.	12 Aug 2025	31.00 (571.00%)	购买	4.44

该时间范围内无数据。

日期	类型	细节
29 Aug 2025	公告	New to The Street T.V. Broadcasting on Bloomberg Saturday Aug 30th. The episode features TON Strategy Company (NASDAQ: TONX), Laser Photonics (NASDAQ: LASE), Sullivan & Cromwell Senior M&A Partner Frank Aquila, and Mercurity Fintech (NASDAQ: MFH)
12 Aug 2025	公告	Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
03 Aug 2025	公告	New to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion Rate
31 Jul 2025	公告	Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
24 Jul 2025	公告	Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update
17 Jun 2025	公告	Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI
17 Jun 2025	公告	/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./
09 Jun 2025	公告	New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days
09 Jun 2025	公告	Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference

支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

没有符合您标准的股票

资产报酬率 (ROA TTM)	-106.68%
股东权益报酬率 (ROE TTM)	-285.79%